IRCT201501183236N6
Completed
Phase 2
Effect of L-arginine supplementation on biochemical and anthropometirc indices associated with cardiovascular diseases
Overview
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 75
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •both sexes; BMI higher than than 29\.9 kg/m2 or visceral obesity (BMI whithin25\- 29\.9 kg/m2 and wc more than 102 cm in men or more than 88 in women); acute or chronic inflammation; stable body weight 3 months before the start of the study (based on self report) absence of any current diet or supplement treatment; absence of antidiabetic, antihypertensive, antihyperlipidemic treatment; no history of ischemic heart disease; and normal renal and liver function. Exclusion criteria: Unwillingness to continue; the use of tobacco or alcohol during the study; taking any supplements other than the selected intervention; any disease or physiological changes that requires special treatment; failure to follow the intervention designing (not consuming dedicated supplement to the total amount less than 90% predicted or more than 3 days).
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Effect of arginine on chronic anal fissureIRCT20190712044182N1Iran University of Medical Sciences76
Completed
Not Applicable
The effect of L- arginine supplementation on metabolic syndrome.Metabolic Syndrome.-IRCT2015120425245N2for research of Yazd Shahid Sadoughi University of Medical Sciences60
Recruiting
Phase 3
The effect of oral L-arginine supplementation on improvement of cardiovascular function and pulmonary artery pressure in patients with major and Intermedia beta-thalassemiaBetha thalasemia.Beta thalassemiaD56.1IRCT20210220050430N1Iran University of Medical Sciences88
Completed
Phase 2
Effect of sports supplements L- Arginine on athletic performancePrevention of cardiovascular disease risk and improve exercise performance in healthy subjects.Other general examinationsIRCT2013121515807N1Research Deputy of Isfahan University of Medical Sciences50
Completed
Phase 3
Investigating the effectiveness of L-arginine in reducing duration of hospitalization and pain intensity of children with sickle cell disease compared to placebo.Sickle cell disease.Other sickle-cell disorders with crisisD57.81IRCT20170112031891N2Ahvaz University of Medical Sciences120